Some probiotic descriptions and
study-proven benefits
GIT = Gastro-Intestinal Tract; IBS = Irritable Bowel Syndrome
|
|
Probiotic:
|
Type
|
Where in body
|
Study proven health
benefits
|
|
Bifidbacterium infantis
|
Anaerobic
Gram +
Branched Rod-shaped
Produces lactic acid from lactose or other sugars
Non-motile
Non-spore-forming
|
GIT of
infants
GIT
Vagina
|
Technically called Bifidobacterium
longum subsp. infantis. Among first to
inhabit sterile newborn GIT, predominating in breast-fed infants.
Different microflora in formula-fed infants may contribute to their
higher risk of diarrhea and allergies
Important inhabitant in body -inhibits pathogenic GIT bacterial growth (ferments sugars into
lactic acid), boosts immune system, aids basic
digestion/metabolism/well-being ;
B. infantis 35624 (Bifantis)benefits
IBS symptoms (E.g. bloating, gas, diarrhea, constipation, urgency,
abdominal discomfort) (Study by manufacturer. Website:
www.aligngi.com).
|
|
Bifidobacterium animalis
subsp. Lactis
|
Colon
|
Attenuates
onset of inflammation in murine colitis.
B. animalis DN-173 010(Bifidus
regularis)-benefits GI symptoms
|
|
Bifidobacterium bifidum
|
GIT
Vagina
|
Bifidobacterium bifidum 17 partially protected mice from chemically induced inflammatory
bowel disease.
Effective treatment I diarrhea (with
L. Acidophilus)
|
|
Bifidobacterium longum
|
GIT
Vagina
|
Technically
called Bifidobacterium longum
subsp. Longum;
Described a
s one of most important types of probiotic in the human body;
Found to
reduce inflammation and IBS symptoms; may reduce risk of colon
cancer;
B. longum seems to protect mice from potentially
deadly E. coli O157: H7 infection
|
|
Lactobacilllus rhamnosus
|
Produces lactic acid from lactose or other sugars
Gram +
Non-spore-forming
Facultative anaerobic
(adapt to produce energy with or without oxygen)
|
GIT
|
Inhibits
growth of most intestinal pathogenic bacteria (releases acids,
bacteriocins, H2O2);
Protects
urogenital tract (excretes biosurfactants to inhibit adhesion of
vaginal/urinary pathogens)
Natural
preservative in yogurt/other dairy products
L. rhamnosus GG shown toreduce risk of respiratory tract infections and prevent
rotavirus diarrhea in children and prevent other types of diarrhea
in adults and children. Patent claims stability in stomach/bile
acids.
L. rhamnosus GG has shown potential in
treatment/prevention of atopic dermatitis.
|
|
LACTOBACILLUS
ACIDOPHULUS
|
GIT
Mouth,
Vagina
|
Acid
conditions help control yeast infections;
Produces
amylase enzyme (digests carbohydrates)
Blend
including L. Acidophilus
decreased incidence of pediatric diarrhea;
Significantly decreased toxic amines in blood of dialysis patients
w/small intestinal bacterial overgrowth
At an
adequate dose may overcome lactose intolerance issues;
Supplementation to cattle reduced
Escherichia coli
0157:H7 by 61%;
May help
reduce blood cholesterol levels
|
|
LACTOBACILLUS bulgaricus
|
|
Converts
only lactose into lactic acid (yogurt's tart flavor/preservative)
and produces acetaldehyde (yogurt's aroma);Helpful for lactose
intolerance;
With L casei, L bulgaricus, and S thermophilus reduced incidence of antibiotic- /C.
Difficile- associated diarrhea
|
|
LACTOBACILLUS
CASEI
|
GIT
Mouth
LAP
|
Wide
pH/temp range; complements L. Acidophilus;
L. casei DN-114001, and L. casei Shirota extensively studied and
widely available; regulates bowel function, helps fight GI
infections;
|
|
LACTOBACILLUS
PLANTARUM
|
Saliva
GIT
|
Ferments
sugars to lactic acid;
Used to
reduce allergies from soy flour;
Produce
antimicrobial (G+ and G-) substances to aid survival in GIT;
Aerotolerant
species
|
|
Streptococcus
thermophilus
|
|
|
NOT A
PROBIOTIC - since it does not survive stomach acid;
Note: Not all
streptococci are pathogenic
E.g. Used to
produce swiss cheese and yogurt (as a mandatory ingredient).
|
